Display options
Cite
Tamberg L, Sepp M, Timmusk T, et al. Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless. Biol Open. 2015;4(12):1762-71doi: 10.1242/bio.014696.
Tamberg, L., Sepp, M., Timmusk, T., & Palgi, M. (2015). Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless. Biology open, 4(12), 1762-71. https://doi.org/10.1242/bio.014696
Tamberg, Laura, et al. "Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless." Biology open vol. 4,12 (2015): 1762-71. doi: https://doi.org/10.1242/bio.014696
Tamberg L, Sepp M, Timmusk T, Palgi M. Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless. Biol Open. 2015 Nov 30;4(12):1762-71. doi: 10.1242/bio.014696. PMID: 26621827; PMCID: PMC4736037.
Copy Download .nbib Format: NLM
Share it on

Biol Open. 2015 Nov 30;4(12):1762-71. doi: 10.1242/bio.014696.

Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless.

Biology open

Laura Tamberg, Mari Sepp, Tõnis Timmusk, Mari Palgi

Affiliations

  1. Laboratory of Molecular Neurobiology, Department of Gene Technology, Tallinn University of Technology, Akadeemia Rd.15, Tallinn 12618, Estonia.
  2. Laboratory of Molecular Neurobiology, Department of Gene Technology, Tallinn University of Technology, Akadeemia Rd.15, Tallinn 12618, Estonia [email protected].

PMID: 26621827 PMCID: PMC4736037 DOI: 10.1242/bio.014696

Abstract

Pitt-Hopkins syndrome (PTHS) is caused by haploinsufficiency of Transcription factor 4 (TCF4), one of the three human class I basic helix-loop-helix transcription factors called E-proteins. Drosophila has a single E-protein, Daughterless (Da), homologous to all three mammalian counterparts. Here we show that human TCF4 can rescue Da deficiency during fruit fly nervous system development. Overexpression of Da or TCF4 specifically in adult flies significantly decreases their survival rates, indicating that these factors are crucial even after development has been completed. We generated da transgenic fruit fly strains with corresponding missense mutations R578H, R580W, R582P and A614V found in TCF4 of PTHS patients and studied the impact of these mutations in vivo. Overexpression of wild type Da as well as human TCF4 in progenitor tissues induced ectopic sensory bristles and the rough eye phenotype. By contrast, overexpression of Da(R580W) and Da(R582P) that disrupt DNA binding reduced the number of bristles and induced the rough eye phenotype with partial lack of pigmentation, indicating that these act dominant negatively. Compared to the wild type, Da(R578H) and Da(A614V) were less potent in induction of ectopic bristles and the rough eye phenotype, respectively, suggesting that these are hypomorphic. All studied PTHS-associated mutations that we introduced into Da led to similar effects in vivo as the same mutations in TCF4 in vitro. Consequently, our Drosophila models of PTHS are applicable for further studies aiming to unravel the molecular mechanisms of this disorder.

© 2015. Published by The Company of Biologists Ltd.

Keywords: Daughterless; Drosophila melanogaster; Intellectual disability; Nervous system; Pitt-Hopkins syndrome; bHLH

References

  1. Biol Psychiatry. 2012 Oct 15;72(8):651-4 - PubMed
  2. Development. 1993 Jun;118(2):401-15 - PubMed
  3. Am J Hum Genet. 2007 May;80(5):988-93 - PubMed
  4. PLoS Genet. 2015 Jan 08;11(1):e1004911 - PubMed
  5. Pharmacol Rev. 2011 Jun;63(2):411-36 - PubMed
  6. Curr Top Behav Neurosci. 2011;7:37-60 - PubMed
  7. Am J Hum Genet. 2007 May;80(5):994-1001 - PubMed
  8. Development. 1994 Apr;120(4):935-45 - PubMed
  9. Development. 2001 Dec;128(23):4705-14 - PubMed
  10. Cell. 2012 Apr 27;149(3):525-37 - PubMed
  11. Exp Mol Med. 2013 May 03;45:e21 - PubMed
  12. Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:326-42 - PubMed
  13. PLoS One. 2011;6(7):e22138 - PubMed
  14. Hum Mutat. 2012 Jan;33(1):64-72 - PubMed
  15. Dev Biol. 2014 Aug 15;392(2):256-65 - PubMed
  16. Hum Mol Genet. 2007 Jun 15;16(12):1488-94 - PubMed
  17. Mech Dev. 1993 Aug;42(3):159-69 - PubMed
  18. Mol Cell Biol. 2012 Nov;32(22):4534-48 - PubMed
  19. EMBO Rep. 2008 Nov;9(11):1128-33 - PubMed
  20. Hum Mutat. 2012 Dec;33(12):1676-86 - PubMed
  21. Cell. 2011 Nov 11;147(4):881-92 - PubMed
  22. Development. 2010 Mar;137(5):705-14 - PubMed
  23. Aust Paediatr J. 1978 Sep;14(3):182-4 - PubMed
  24. Mol Cell Biol. 2000 Jan;20(2):429-40 - PubMed
  25. Hum Mutat. 2009 Apr;30(4):669-76 - PubMed
  26. Cell. 1989 Mar 10;56(5):777-83 - PubMed
  27. Development. 2001 Aug;128(16):3145-59 - PubMed
  28. Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9715-20 - PubMed
  29. Cell. 1987 Feb 13;48(3):479-87 - PubMed
  30. Hum Mol Genet. 2012 Jul 1;21(13):2873-88 - PubMed
  31. Genes Dev. 1988 Jul;2(7):843-52 - PubMed
  32. Dev Biol. 1996 Oct 10;179(1):65-78 - PubMed
  33. Genes Dev. 1998 Jul 1;12(13):2036-47 - PubMed
  34. EMBO J. 1991 Oct;10(10):2965-73 - PubMed
  35. Mech Dev. 1997 Apr;63(1):75-87 - PubMed
  36. Dev Genet. 1997;21(2):117-22 - PubMed
  37. NeuroRx. 2005 Jul;2(3):438-46 - PubMed
  38. Cell. 1995 Jul 14;82(1):67-76 - PubMed
  39. Dev Biol. 2008 May 15;317(2):417-29 - PubMed
  40. Trends Mol Med. 2014 Jun;20(6):322-31 - PubMed
  41. Development. 2002 Jul;129(13):3255-67 - PubMed
  42. Genes Dev. 1993 Sep;7(9):1703-13 - PubMed

Publication Types

Grant support